Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/content/pdf/10.1007/BF00941899.pdf
Reference46 articles.
1. Allan DJ, Howell A, Roberts SA, Williams GT, Watson RJ, Coyne JD, Clarke RB, Laidlaw IJ, Porten CS (1992) Reduction of apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast. J Pathol 167:25
2. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:921
3. Barbareschi M, Iuzzolino P, Pennella A, Allegranza A, Arrigoni G, Dalla-Palma P, Doglioni C (1992) p53 protein expression in central nervous system neoplasms. J Clin Pathol 45:583
4. Brown DC, Gatter KC0 (1990) Monoclonal antibody Ki-67:its use in histopathology. Histopathology 17:489
5. Cattoretti G, Becker MHG, Key G, Duchrow M Schlüter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Progress in the Research and Targeted Therapy of ErbB/HER Receptors in Urothelial Bladder Cancer;Frontiers in Molecular Biosciences;2021-12-23
2. Biomarkers in bladder cancer: Translational and clinical implications;Critical Reviews in Oncology/Hematology;2014-01
3. Therapeutic potential of sepantronium bromide YM155 in gemcitabine-resistant human urothelial carcinoma cells;Oncology Reports;2013-11-28
4. Tissue-based Biomarkers;Bladder Pathology;2012-07-09
5. Ki-67, p53, bcl-2 and bax expression in urothelial carcinomas of urinary bladder;Turkish Journal of Pathology;2010
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3